News and publications
Tricia Ellis and Toto Gronlund in conversation: our two newest JLA Advisers talk about what the JLA means to them
12 December 2017The JLA's two newest Advisers, Tricia Ellis and Toto Gronlund, reflect on why they joined the JLA, what it means to them and how far they think it can go.
08 November 2017The Type 2 Diabetes Priority Setting Partnership (T2D PSP) has just announced its top 10 priorities. With input from over 4000 people who submitted over 8000 ideas for research, this has been one of the JLA’s larger PSPs. As their involvement on the project comes to an end, Steering Group members reflect on the experience from their individual perspectives.
13 September 2017Douglas Findlay, Steering Group member, Emergency Medicine Priority Setting Partnership, looks back over the course of the priority setting process he was a part of. He explains why he believes the work of the James Lind Alliance is so valuable, and why he would encourage others to get involved.
31 July 2017It’s important that Priority Setting Partnerships (PSPs) think about the people they are trying to talk to and how to make it as easy as possible for them to get involved. The Canadian Dementia PSP has announced its Top 10 recently and made some interesting adjustments to help people with a diagnosis of dementia to join in with the priority setting
Does current palliative and end of life care research match the priorities of patients, carers and clinicians?
18 July 2017Marie Curie has published a report looking at how current and recently completed health research in the UK relates to each of the 83 questions prioritised by the Palliative and end of life care PSP
14 June 2017Emily Burns, Research Communications Manager at Diabetes UK, reflects on her experience as a participant in the Contraception PSP Final Workshop. Emily describes the process, and relates this to her work with the Type 2 Diabetes PSP, which is currently planning its own final workshop.
17 May 2017Marie Curie announces £1.5 million joint funding call to address gaps in palliative and end of life care research
31 March 2017A horizon scanning review has been produced by the NIHR Horizon Scanning Research & Intelligence Centre (HSRIC) on new and emerging technologies for hearing loss. This review was done in response to research questions prioritised by the Mild to Moderate Hearing Loss PSP in 2015.
29 March 2017Marie Curie, in partnership with the Scottish Government Chief Scientist Office (CSO) and the Motor Neurone Disease (MND) Association, has announced the research grants awarded to address research questions identified by the Palliative and end of life care PSP.
01 February 2017Professor Deborah Hall, from the NIHR Nottingham Hearing Biomedical Research Unit, together with the British Tinnitus Association, has been keeping track of all the research that is aimed at the Top 10 priorities of the Tinnitus PSP.
17 January 2017In May 2016, the Autism PSP published its Top 10. Since then, Autistica, the charity which initiated the PSP, has been working with funders and putting plans in place to address these research priorities.
04 January 2017We’re pleased to announce that the James Lind Alliance (JLA) is seeking to recruit JLA Advisers to join the team. We are looking for skilled individuals who will support and facilitate JLA Priority Setting Partnerships.
16 November 2016The top 10 research priorities for alcohol-related liver disease have been identified by a James Lind Alliance PSP, which was jointly funded by the NIHR and the British Society of Gastroenterology (BSG).
Looking beyond the PSP interventions: a thematic analysis of the perceptions and experiences of people in palliative and end of life care
08 November 2016Dr Annmarie Nelson, of Marie Curie, explores the broader issues and concerns raised by patients, families and health professionals, which went beyond the priority research questions identified by the Palliative and end of life care PSP.
18 October 2016Catherine White, one of the new JLA Advisers, describes her personal journey into the world of medical research, and shares her initial insights into the JLA process.